Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Dermata Therapeutics, Inc. | Senior VP, CDO | Stock Option (right to buy | 50K | Jan 4, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
DRMA | Dermata Therapeutics, Inc. | Jan 4, 2024 | 1 | $0 | 4 | Jan 5, 2024 | Senior VP, CDO |
DRMA | Dermata Therapeutics, Inc. | Jan 3, 2023 | 1 | $0 | 4 | Jan 5, 2023 | Senior VP, CDO |
DRMA | Dermata Therapeutics, Inc. | Jul 1, 2022 | 1 | $0 | 4 | Jul 7, 2022 | Senior VP, CDO |
DRMA | Dermata Therapeutics, Inc. | Jan 3, 2022 | 1 | $0 | 4 | Jan 5, 2022 | Senior VP, Development |
DRMA | Dermata Therapeutics, Inc. | Aug 17, 2021 | 2 | $0 | 4 | Aug 17, 2021 | Senior VP, Development |
DRMA | Dermata Therapeutics, Inc. | Aug 12, 2021 | 0 | $0 | 3 | Aug 12, 2021 | Senior VP, Development |